Co-Authors
This is a "connection" page, showing publications co-authored by Lawrence Kushi and Carlos Iribarren.
Connection Strength
0.481
-
Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
Score: 0.062
-
Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study. JNCI Cancer Spectr. 2024 Feb 29; 8(2).
Score: 0.059
-
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Res Sq. 2023 Mar 22.
Score: 0.055
-
Reply to M.S. Ewer et al. J Clin Oncol. 2022 Jul 25; JCO2201353.
Score: 0.053
-
Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Res Treat. 2022 Jun; 193(3):669-675.
Score: 0.052
-
Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
Score: 0.052
-
Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 Jan 13; JCO2101738.
Score: 0.051
-
Characterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort. Genetics. 2015 Aug; 200(4):1285-95.
Score: 0.032
-
Automated Assay of Telomere Length Measurement and Informatics for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort. Genetics. 2015 Aug; 200(4):1061-72.
Score: 0.032
-
Genotyping Informatics and Quality Control for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort. Genetics. 2015 Aug; 200(4):1051-60.
Score: 0.032